Oncocross

Biotech · Seoul, KR

AI drug-discovery company advancing sarcopenia and reperfusion-injury pipelines.

Funding history

Date	Round	Amount
Nov 2023	Funding round AI drug-discovery company Oncocross raised KRW 14.5B to advance its pipeline ahead of a planned 2024 listing.	$11M